| ID | Analyse | Domein | Recipiënt | Uitvoering | LTAT (uren (dagen)) | Accred. | LOINCeenheid (1) | LOINCeenheid (2) | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 23285 | AMA-M2 ... AMA-M2, Anti-lever Antistoffen, Anti-LKM | Serum |
186 (7,7) | – | 85092-5 | – | › | |||
| 71020 | Amandel f20 IgG | Serum |
2× per week, op dinsdag en vrijdag | – | 60348-0 mgA/l | – | › | |||
| 57820 | Amandelz.- Fenylglyoxylz. | Urine |
260 (10,8) | – | 47697-8 | – | › | |||
| 58671 | Amfetaminen bevestiging | Urine |
144 (6) | – | 16369-1 | – | › | |||
| 59202 | Amfetaminen haar | Haar |
379 (15,8) | – | – | – | › | |||
| 59270 | Amfetamines (serum) | Serum |
480 (20) | – | 8148-9 | – | › | |||
| 28044 | Amfetamines screening | Urine |
– | – | – | › | ||||
| 25053 | AMH AMH, Müllerian inhibiting factor (MIF), Müllerian inhibiting hormone (MIH) | Serum |
23 (1) | – | – | – | › | |||
| 5978 | Amikacine Dal Amukin | Serum |
291 (12,1) | – | 3321-7 mg/l | – µmol/L | › | |||
| 5980 | Amikacine Piek Amukin | Serum |
– | 3319-1 µg/ml | – µmol/L | › | ||||
| 7031 | Aminozuren kwantitatief | Urine |
1× per 1–2 weken | 215 (9) | – | 74991-1 | – | › | ||
| 2642 | Aminozuren kwantitatief | Heparine (Lithium-heparinebuis) |
2× per week | 303 (12,6) | – | 1913-3 | 35083-5 | › | ||
| 55618 | Amiodarone Cordarone | Serum |
239 (9,9) | – | 3330-8 | 15099-5 | › | |||
| 6003 | Amisulpride | Serum |
256 (10,6) | – | 85384-6 µg/L | – | › | |||
| 55864 | Amitriptyline Redomex, Sarotex | Serum |
159 (6,6) | – | 14597-9 | – | › | |||
| 22379 | Ammoniak | EDTA |
maandag t/m vrijdag | 4 (0,2) | – | 32664-5 ug/dL | 1839-0 umol/L | › | ||
| 26910 | Amylase | Urine |
maandag t/m vrijdag | 26 (1,1) | – | 1799-6 U/L | – | › | ||
| 22400 | Amylase | Serum |
maandag t/m vrijdag | 1 (0,1) | B | 1798-8 U/L | – | › | ||
| 28794 | Amylase | Punctievocht (Ascites / Pleura / Pericard) |
maandag t/m vrijdag | – | 1795-4 U/L | – | › | |||
| 26926 | Amylase/creatinine clear. Amylase/creatinine klaring | Serum Urine |
122 (5,1) | – | – | – | › | |||
| 23140 | ANA (HEp-2, 1/80) ANA, ANF, Antinucleaire antilichamen | Serum |
maandag t/m vrijdag | 72 (3) | B | 59069-5 | – | › | ||
| 71210 | Ananas f210 IgG | Serum |
2× per week, op dinsdag en vrijdag | – | – mgA/l | – | › | |||
| 23145 | Anaplasma phagocyt. hond | Serum |
1× per week | 174 (7,2) | – | – | – | › | ||
| 3199 | Anaplasma phagocyt.paard | Serum |
maandag t/m vrijdag | 153 (6,4) | – | – | – | › | ||
| 4390 | Anaplasma phagocytophilum | Serum |
– | – | – | › | ||||
| 24263 | Anaplasma phagocytophilum | EDTA |
2× per week | 93 (3,9) | – | – | – | › | ||
| 4458 | Anaplasma platys PCR | EDTA |
1× per week | 143 (6) | – | – | – | › | ||
| 23260 | ANCA/MPO/PR3 diagnose Anti-MPO, Anti-Myeloperoxidase, Anti-PR3 | Serum |
65 (2,7) | – | 46266-3 | – | › | |||
| 90550 | Ander | Biopsie |
78 (3,2) | – | – | – | › | |||
| 8437 | Andere PCR testen | EDTA |
– | – | – | › | ||||
| ● 34353 | Androstaandiolglucuronide 3 alfa-diol glucuronide, 5 alfa-androstaan-3 alfa-17 beta-diol-glucuronide, 5 alfa-androstane-3 alfa-17 beta-diol-glucuronide | Serum |
2× per week | – | 1680-8 ng/mL | 15008-6 nmol/L | › | |||
| 57120 | Androsteendion Delta-4-androsteendion | Serum |
3× per week | 145 (6) | – | – ng/dL | 14603-5 nmol/L | › | ||
| 4434 | Angiostrong. vasorum PCR | Faeces |
maandag t/m vrijdag | 138 (5,8) | – | – | – | › | ||
| 24319 | Angiostrongylus vasorum Longworm serologie | Serum |
maandag t/m vrijdag | 5 (0,2) | – | – | – | › | ||
| 22652 | Angiotensine conv. enzym ACE, Kininase II | Serum |
maandag t/m vrijdag | 22 (0,9) | – | 2742-5 U/L | – | › | ||
| 22141 | Aniongap | Serum |
1 (0) | – | – | – | › | |||
| 4328 | Anisakis (ELISA) Haringwormziekte antistoffen | Serum |
1× per 2 weken | 197 (8,2) | – | – | – | › | ||
| 23337 | Anti-Aquaporine-4 (1/1) Anti-NMO (1/1) | Lumbaalvocht (CSV) |
1× per 1–2 weken | 129 (5,4) | – | – | – | › | ||
| 23282 | Anti-Aquaporine-4 (1/10) Anti-NMO (1/10) | Serum |
1× per 1–2 weken | 46 (1,9) | – | 43638-6 | – | › | ||
| 23338 | Anti-Aquaporine-4 titer | Lumbaalvocht (CSV) |
– | – | – | › | ||||
| 23336 | Anti-Aquaporine-4 titer | Serum |
99 (4,1) | – | 95273-9 | – | › | |||
| 23332 | Anti-beta2 glycoproteïne | Serum |
57 (2,4) | – | – | – | › | |||
| 23308 | Anti-cardiolipine IgG Anti-fosfolipiden antistoffen, Cardiolipine IgG | Serum |
maandag t/m vrijdag | 26 (1,1) | – | 3181-5 GPL U/ml | – | › | ||
| 23307 | Anti-cardiolipine IgM Anti-fosfolipiden antistoffen, Cardiolipine IgM | Serum |
maandag t/m vrijdag | 26 (1,1) | – | 3182-3 MPL U/ml | – | › | ||
| 23138 | Anti-CCP Anti-Cyclic Citrullinated Peptide, Cyclic Citrullinated Peptide Antibody, Cyclisch gecitrullineerde peptiden | Serum |
maandag t/m vrijdag | 3 (0,1) | – | 53027-9 U/ml | – | › | ||
| 24006 | Anti-Endomysium IgA 1/10 | Serum |
tenminste 1× per week | 156 (6,5) | – | 46126-9 | – | › | ||
| 24021 | Anti-Endomysium IgG 1/10 | Serum |
tenminste 1× per week | 26 (1,1) | – | 39554-1 | – | › | ||
| 1342 | anti-factor Xa | Citraat |
1× per week | 96 (4) | – | 3216-9 IU/ml | – | › | ||
| 22591 | anti-GAD Anti Glutamic Acid Decarboxylase 65 antistoffen, GAD65 antistoffen, GADA | Serum |
1× per 1–2 weken | 175 (7,3) | – | 56540-8 IU/mL | – | › | ||
| 3258 | anti-ganglioside AS | Serum |
667 (27,8) | – | 82455-7 | – | › |
